Taisho have entered in to an agreement with Chugai to co-market ED-71, an activated vitamin D derivative that Chugai is currently developing in Japan for the treatment of osteoporosis … more →
Nuclear Receptor Newscrimsoncanary wrote 3 months ago: Taisho have entered in to an agreement with Chugai to co-market ED-71, an activated vitamin D deriv … more →